Photo of Neil P. Stronski

Neil P. Stronski

Partner, Skadden

212-735-2839neil.stronski@skadden.com

One Manhattan West
New York, NY 10001

View Firm Biography

Neil P. Stronski concentrates in mergers and acquisitions, corporate governance, securities law and general corporate matters.

Stronski has represented acquirers, targets and financial advisors in a number of significant U.S. and international mergers and acquisitions, including public and private transactions, negotiated and contested acquisitions, and other corporate matters.

Lawdragon Honors

Honor Year Practice
The 2027 Lawdragon 500 Leading Dealmakers 2027 M&A, Corporate Governance, Securities

He has represented:

  • Mars, Inc. in numerous transactions, including its acquisition of Kellanova, acquisition of VCA, Inc., acquisition of BluePearl Veterinary Partners LLC, acquisition of Procter & Gamble’s pet business, acquisition of Pet Partners, and sale of its private label pet food business
  • Pinnacle Entertainment in its acquisition by Penn National Gaming, Inc., and the spin-off of its gaming operations and acquisition of its real estate by Gaming and Leisure Properties, Inc.
  • Edwards Lifesciences in the $4.2 billion sale of its Critical Care business to Becton, Dickinson and Company
  • Tamko Building Products in connection with an investment by The Carlyle Group and related corporate matters
  • Merck KGaA in a number of transactions, including its acquisition of Sigma-Aldrich Corporation, and sale of its crop bioscience business to Novozymes A/S
  • Serono S.A. and the Bertarelli Family in the acquisition of Serono by Merck KGaA
  • Cephalon, Inc. in connection with the unsolicited proposal made by Valeant Pharmaceuticals International, Inc. and in its subsequent merger with Teva Pharmaceutical Industries Ltd.
  • Morgan Stanley in the sale of its interest in China International Capital Corporation
  • Alcoa Inc. in its proposed, but terminated, unsolicited acquisition of Alcan Inc.
  • UnitedHealth Group Incorporated in its acquisition of Oxford Health Plans, Inc.
  • AdvancePCS in its merger with CaremarkRx, Inc.
  • Mobil Corporation in its merger with Exxon Corporation
  • MacMillan Bloedel Limited in its acquisition by Weyerhauser Company